118 related articles for article (PubMed ID: 30027096)
21. HPV16 E5 deregulates the autophagic process in human keratinocytes.
Belleudi F; Nanni M; Raffa S; Torrisi MR
Oncotarget; 2015 Apr; 6(11):9370-86. PubMed ID: 25826082
[TBL] [Abstract][Full Text] [Related]
22. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
Cerasuolo A; Annunziata C; Tortora M; Starita N; Stellato G; Greggi S; Maglione MG; Ionna F; Losito S; Botti G; Buonaguro L; Buonaguro FM; Tornesello ML
Oncotarget; 2017 May; 8(21):34070-34081. PubMed ID: 28423662
[TBL] [Abstract][Full Text] [Related]
24. Analysis of antibody response to HPV 16 and HPV 18 antigens in Tunisian patients.
Achour M; Kahla S; Zeghal D; Kochbati L; Mongi M; Zouari F; Oueslati R
Viral Immunol; 2009 Feb; 22(1):7-16. PubMed ID: 19210223
[TBL] [Abstract][Full Text] [Related]
25. Immunogenic properties of human papilloma virus type 16 (HPV-16) E5 polypeptide.
Gill D; Cason J; Punchard N
Biochem Soc Trans; 1997 May; 25(2):281S. PubMed ID: 9191325
[No Abstract] [Full Text] [Related]
26. Purification and Characterization of Antibodies in Single-Chain Format against the E6 Oncoprotein of Human Papillomavirus Type 16.
Verachi F; Percario Z; Di Bonito P; Affabris E; Amici C; Accardi L
Biomed Res Int; 2018; 2018():6583852. PubMed ID: 29888271
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus does not have a causal role in colorectal carcinogenesis.
Lorenzon L; Mazzetta F; Pilozzi E; Uggeri G; Torrisi MR; Ferri M; Ziparo V; French D
World J Gastroenterol; 2015 Jan; 21(1):342-50. PubMed ID: 25574110
[TBL] [Abstract][Full Text] [Related]
28. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
[TBL] [Abstract][Full Text] [Related]
29. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells.
Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V
Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629
[TBL] [Abstract][Full Text] [Related]
30. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo.
Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D
Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977
[TBL] [Abstract][Full Text] [Related]
32. Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls.
Achour M; Zeghal D; Kochbati L; Kahla S; Zouari F; Maalej M; Oueslati R
J Immunoassay Immunochem; 2008; 29(3):266-80. PubMed ID: 18569375
[TBL] [Abstract][Full Text] [Related]
33. Programmable protein arrays for immunoprofiling HPV-associated cancers.
Ewaisha R; Meshay I; Resnik J; Katchman BA; Anderson KS
Proteomics; 2016 Apr; 16(8):1215-24. PubMed ID: 27089055
[TBL] [Abstract][Full Text] [Related]
34. [Human papillomavirus type 16 E5 sequence evolution analysis].
Hao M; Wu XZ; Wang XL; Bian ML; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):452-4. PubMed ID: 20718354
[TBL] [Abstract][Full Text] [Related]
35. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
37. [Association between human papilloma virus late 1 protein and cervical neoplasia].
Zhang L; Niyazi M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):571-4. PubMed ID: 22338145
[TBL] [Abstract][Full Text] [Related]
38. The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.
Stöppler MC; Straight SW; Tsao G; Schlegel R; McCance DJ
Virology; 1996 Sep; 223(1):251-4. PubMed ID: 8806560
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic associations of HPV-positive oropharyngeal cancer and (pre)cancerous cervical lesions.
Rietbergen MM; van Bokhoven AAJD; Lissenberg-Witte BI; Heideman DAM; Leemans CR; Brakenhoff RH; Bloemena E
Int J Cancer; 2018 Jul; 143(2):283-288. PubMed ID: 29441569
[TBL] [Abstract][Full Text] [Related]
40. CD1d, a sentinel molecule bridging innate and adaptive immunity, is downregulated by the human papillomavirus (HPV) E5 protein: a possible mechanism for immune evasion by HPV.
Miura S; Kawana K; Schust DJ; Fujii T; Yokoyama T; Iwasawa Y; Nagamatsu T; Adachi K; Tomio A; Tomio K; Kojima S; Yasugi T; Kozuma S; Taketani Y
J Virol; 2010 Nov; 84(22):11614-23. PubMed ID: 20810727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
